| BYLD | FBND | BYLD / FBND | |
| Gain YTD | 0.461 | -0.259 | -178% |
| Net Assets | 447M | 27B | 2% |
| Total Expense Ratio | 0.13 | 0.36 | 36% |
| Turnover | 96.00 | 246.00 | 39% |
| Yield | 5.34 | 4.69 | 114% |
| Fund Existence | 12 years | 12 years | - |
| BYLD | FBND | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 45% | N/A |
| Stochastic ODDS (%) | 2 days ago 51% | 2 days ago 57% |
| Momentum ODDS (%) | 2 days ago 40% | 2 days ago 50% |
| MACD ODDS (%) | 2 days ago 35% | 2 days ago 52% |
| TrendWeek ODDS (%) | 2 days ago 44% | 2 days ago 54% |
| TrendMonth ODDS (%) | 2 days ago 42% | 2 days ago 53% |
| Advances ODDS (%) | 10 days ago 41% | 10 days ago 53% |
| Declines ODDS (%) | 2 days ago 40% | 2 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 47% | 2 days ago 52% |
| Aroon ODDS (%) | 2 days ago 49% | N/A |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMEQ | 68.36 | N/A | N/A |
| Nomura Focused Emerging Mrkts Eq ETF | |||
| CPSO | 27.96 | N/A | N/A |
| Calamos S&P 500 Str Alt Prt ETF-Oct | |||
| DCRE | 51.53 | -0.05 | -0.09% |
| DoubleLine Commercial Real Estt Dbt ETF | |||
| ITDF | 40.77 | -0.47 | -1.15% |
| iShares LifePath Target Date 2050 ETF | |||
| TSPA | 46.64 | -0.60 | -1.27% |
| T. Rowe Price US Equity Research ETF | |||
A.I.dvisor tells us that FBND and CZR have been poorly correlated (+17% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBND and CZR's prices will move in lockstep.
| Ticker / NAME | Correlation To FBND | 1D Price Change % | ||
|---|---|---|---|---|
| FBND | 100% | -0.20% | ||
| CZR - FBND | 17% Poorly correlated | -0.13% | ||
| NFE - FBND | 0% Poorly correlated | +1.55% | ||
| CRC - FBND | -1% Poorly correlated | +0.76% | ||
| EQT - FBND | -8% Poorly correlated | -1.15% |